- Company Overview for ELASTRIN THERAPEUTICS LIMITED (14203760)
- Filing history for ELASTRIN THERAPEUTICS LIMITED (14203760)
- People for ELASTRIN THERAPEUTICS LIMITED (14203760)
- More for ELASTRIN THERAPEUTICS LIMITED (14203760)
Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
---|---|---|---|
15 Jul 2024 | CS01 | Confirmation statement made on 28 June 2024 with updates | |
04 Jun 2024 | AA | Total exemption full accounts made up to 31 December 2023 | |
26 Mar 2024 | TM01 | Termination of appointment of Alison Ruth Carter as a director on 26 March 2024 | |
26 Mar 2024 | TM01 | Termination of appointment of David Alexander Brindley as a director on 26 March 2024 | |
26 Jul 2023 | AA | Total exemption full accounts made up to 31 December 2022 | |
11 Jul 2023 | CS01 | Confirmation statement made on 28 June 2023 with updates | |
05 Jul 2023 | PSC05 | Change of details for Elastrin Therapeutics Inc. as a person with significant control on 27 June 2023 | |
04 Jul 2023 | CH01 | Director's details changed for Mr Matthias Breugelmans on 27 June 2023 | |
04 Jul 2023 | CH01 | Director's details changed for Dr Alison Ruth Carter on 4 July 2023 | |
04 Jul 2023 | CH01 | Director's details changed for Mr David Alexander Brindley on 27 June 2023 | |
31 Oct 2022 | AD01 | Registered office address changed from 3 the Old Estate Yard High Street East Hendred Wantage Oxfordshire OX12 8JY England to 2 the Old Estate Yard High Street East Hendred Wantage Oxfordshire OX12 8JY on 31 October 2022 | |
29 Jun 2022 | AA01 | Current accounting period shortened from 30 June 2023 to 31 December 2022 | |
29 Jun 2022 | NEWINC |
Incorporation
Statement of capital on 2022-06-29
|